Emily Breidt
About Emily Breidt
Emily Breidt is a Quality Engineer II with a background in chemical engineering and extensive experience in quality assurance and manufacturing within the pharmaceutical industry. She has worked for several companies, including CG Oncology, BioMarin Pharmaceutical Inc., and Gilead Sciences, and currently holds a position at Relievant Medsystems, Inc.
Work at Relievant Medsystems
Emily Breidt currently serves as a Quality Engineer II at Relievant Medsystems, Inc. She has held this position since 2022. In this role, she is responsible for ensuring quality standards are met in the development and manufacturing processes of the company's products.
Previous Experience at CG Oncology
Emily Breidt worked at CG Oncology in various quality assurance roles. She served as a QA Specialist for 11 months from 2021 to 2022, followed by a position as QA Specialist II for 8 months in 2022. Her responsibilities included maintaining compliance with quality standards and regulations.
Background in Pharmaceutical Manufacturing
Emily has a background in pharmaceutical manufacturing, having worked at BioMarin Pharmaceutical Inc. as a Manufacturing Associate for 9 months in 2018. She also held a similar position at Twist Bioscience from 2018 to 2019 for 8 months. Additionally, she worked as a QA Compliance Specialist II at Gilead Sciences for 2 years from 2019 to 2021.
Educational Qualifications
Emily Breidt earned a Bachelor of Science (BS) in Chemical Engineering from the University of Colorado Boulder, where she studied from 2013 to 2017. She also completed her high school education at Fossil Ridge High School, graduating in 2013.
Internship and Early Career Roles
Emily began her career with various internships and assistant roles. She interned at Gilead Sciences as a Regulatory Affairs Chemistry, Manufacturing and Controls Intern for 3 months in 2016. Additionally, she worked as a Lab Intern at Colorado State University for 2 months in 2013 and served as a Teaching Assistant at the University of Colorado Memorial Center from 2014 to 2015.